Copegus and Bleeding into the skin - a phase IV clinical study of FDA data

Summary:

Bleeding into the skin is reported as a side effect among people who take Copegus (ribavirin), especially for people who are male, 40-49 old, have been taking the drug for 1 - 6 months also take Pegasys, and have Hiv infection.

The phase IV clinical study analyzes which people have Bleeding into the skin when taking Copegus. It is created by eHealthMe based on reports of 15,097 people who have side effects when taking Copegus from the FDA, and is updated regularly.

What is Copegus?

Copegus has active ingredients of ribavirin. It is often used in hepatitis c. eHealthMe is studying from 15,115 Copegus users. Check the latest studies of Copegus.

What is Bleeding into the skin?

Bleeding into the skin is found to be associated with 937 drugs and 1,911 conditions by eHealthMe. Check the latest studies of Bleeding into the skin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

15,097 people reported to have side effects when taking Copegus.
Among them, 17 people (0.11%) have Bleeding into the skin.

Could Copegus cause Bleeding into the skin?

Among these 17 people:

How long have people been on Copegus when they have Bleeding into the skin? *

What is the gender of people who have Bleeding into the skin when taking Copegus? *

female: 47.06 %
male: 52.94 %

What is the age of people who have Bleeding into the skin when taking Copegus? *

What are other drugs people take besides Copegus? *

Pegasys: 14 people, 82.35%
Acetaminophen: 5 people, 29.41%
Victrelis: 5 people, 29.41%
Allopurinol: 4 people, 23.53%
Combivir: 4 people, 23.53%
Morphine Sulfate: 4 people, 23.53%
Viread: 2 people, 11.76%
Amoxicillin And Clavulanate Potassium: 2 people, 11.76%
Imodium: 2 people, 11.76%
Moxifloxacin Hydrochloride: 2 people, 11.76%

What are other side effects people have besides Bleeding into the skin? *

Thrombocytopenia (decrease of platelets in blood): 10 people, 58.82%
Nosebleed (bleeding from nose): 8 people, 47.06%
Hepatomegaly (abnormal enlargement of the liver): 6 people, 35.29%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 4 people, 23.53%
Consciousness - Decreased: 4 people, 23.53%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 4 people, 23.53%
Respiratory Distress (difficulty in breathing): 4 people, 23.53%
Ecchymosis (a discoloration of the skin resulting from bleeding underneath): 4 people, 23.53%
Subarachnoid Haemorrhage (blood leaks into the space between two membranes that surround the brain): 3 people, 17.65%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 17.65%

What are the existing conditions these people have? *

Hiv Infection: 4 people, 23.53%
Hepatitis C Virus Test Positive: 2 people, 11.76%
Fever: 2 people, 11.76%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 11.76%
Prostatitis (inflammation of the prostate gland): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Copegus and have Bleeding into the skin?

- Check whether Bleeding into the skin is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Copegus:

Copegus (15,115 reports)

Browse all side effects of Copegus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bleeding into the skin:

Bleeding into the skin (937 drugs)

Browse all the conditions that are associated with Bleeding into the skin:

Bleeding into the skin (1,911 conditions)

Related publications that referenced our studies

Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on ribavirin (the active ingredients of Copegus) and Copegus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.